175 related articles for article (PubMed ID: 34044091)
1. Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T
Kim H; Jin S; Choi H; Kang M; Park SG; Jun H; Cho H; Kang S
J Control Release; 2021 Jul; 335():269-280. PubMed ID: 34044091
[TBL] [Abstract][Full Text] [Related]
2. Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI.
Song Y; Kang YJ; Jung H; Kim H; Kang S; Cho H
Sci Rep; 2015 Oct; 5():15656. PubMed ID: 26493381
[TBL] [Abstract][Full Text] [Related]
3. TRAIL & EGFR affibody dual-display on a protein nanoparticle synergistically suppresses tumor growth.
Jun H; Jang E; Kim H; Yeo M; Park SG; Lee J; Shin KJ; Chae YC; Kang S; Kim E
J Control Release; 2022 Sep; 349():367-378. PubMed ID: 35809662
[TBL] [Abstract][Full Text] [Related]
4. Development of target-tunable P22 VLP-based delivery nanoplatforms using bacterial superglue.
Kim H; Choi H; Bae Y; Kang S
Biotechnol Bioeng; 2019 Nov; 116(11):2843-2851. PubMed ID: 31329283
[TBL] [Abstract][Full Text] [Related]
5. H-ferritin-nanocaged gadolinium nanoparticles for ultra-sensitive MR molecular imaging.
Zhang J; Yuan C; Kong L; Zhu F; Yuan W; Zhang J; Hong J; Deng F; Chen Q; Chen C; Wang T; Zuo Z; Liang M
Theranostics; 2024; 14(5):1956-1965. PubMed ID: 38505606
[No Abstract] [Full Text] [Related]
6. Application of periostin peptide-decorated self-assembled protein cage nanoparticles for therapeutic angiogenesis.
Kim BR; Yoon JW; Choi H; Kim D; Kang S; Kim JH
BMB Rep; 2022 Apr; 55(4):175-180. PubMed ID: 34814976
[TBL] [Abstract][Full Text] [Related]
7. Engineered Nonviral Protein Cages Modified for MR Imaging.
Kaster MA; Levasseur MD; Edwardson TGW; Caldwell MA; Hofmann D; Licciardi G; Parigi G; Luchinat C; Hilvert D; Meade TJ
ACS Appl Bio Mater; 2023 Feb; 6(2):591-602. PubMed ID: 36626688
[TBL] [Abstract][Full Text] [Related]
8. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Lu ZR; Laney V; Li Y
Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
[TBL] [Abstract][Full Text] [Related]
9. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of uniform layer-by-layer assemblies with complementary protein cage nanobuilding blocks via simple His-tag/metal recognition.
Moon H; Kim WG; Lim S; Kang YJ; Shin HH; Ko H; Hong SY; Kang S
J Mater Chem B; 2013 Sep; 1(35):4504-4510. PubMed ID: 32261123
[TBL] [Abstract][Full Text] [Related]
11. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.
Swanson SD; Kukowska-Latallo JF; Patri AK; Chen C; Ge S; Cao Z; Kotlyar A; East AT; Baker JR
Int J Nanomedicine; 2008; 3(2):201-10. PubMed ID: 18686779
[TBL] [Abstract][Full Text] [Related]
12. T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.
Na JH; Lee S; Koo H; Han H; Lee KE; Han SJ; Choi SH; Kim H; Lee S; Kwon IC; Choi K; Kim K
Nanoscale; 2016 May; 8(18):9736-45. PubMed ID: 27113247
[TBL] [Abstract][Full Text] [Related]
13. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
14. Load and Display: Engineering Encapsulin as a Modular Nanoplatform for Protein-Cargo Encapsulation and Protein-Ligand Decoration Using Split Intein and SpyTag/SpyCatcher.
Choi H; Eom S; Kim HU; Bae Y; Jung HS; Kang S
Biomacromolecules; 2021 Jul; 22(7):3028-3039. PubMed ID: 34142815
[TBL] [Abstract][Full Text] [Related]
15. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
16. Enhancing T
Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
18. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
19. Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
Jin J; Xu Z; Zhang Y; Gu YJ; Lam MH; Wong WT
Adv Healthc Mater; 2013 Nov; 2(11):1501-12. PubMed ID: 23630101
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
